LinKinVax

Paris, France

LinKinVax operates as a clinical-stage biotechnology company.

$7.8M raised

Jan 2023

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has LinKinVax raised?

LinKinVax has raised $7.8M in total funding. The most recent round was Series A. The last funding was announced in January 2023.

Who are LinKinVax's investors?

LinKinVax's investors include IQT, Jean-Paul Kress, Geoffrey Duyk, Alain Tingaud, Giorgio Anania.

Where is LinKinVax headquartered?

LinKinVax is headquartered in Paris, France.

What does LinKinVax do?

LinKinVax operates as a clinical-stage biotechnology company.

What stage is LinKinVax at?

LinKinVax is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2023.

MLA

"LinKinVax — Funding & Investors." VCBacked, January 9, 2023, https://www.vcbacked.co/company/linkinvax. Accessed July 2, 2026.

APA

VCBacked. (2023). LinKinVax — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/linkinvax

Wikipedia (cite web)

{{cite web |title=LinKinVax — Funding & Investors |url=https://www.vcbacked.co/company/linkinvax |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2023.